2022
Frankenfeld CL . 2022. Fecal metabolome: New addition to the toolbox for dietary assessment? J Nutr 152(12):2643–2644; doi: 10.1093/jn/nxac233 . PMID: 36288243.
View Abstract
Publication: Manuscripts
/ Topics: biomarkers , nutrition
Sheshadri A, Sacks NC , Healey B, Cyr P , Boerner G, Huang HJ. 2022. The healthcare resource utilization and costs of chronic lung allograft dysfunction following lung transplantation in patients with commercial insurance in the United States. J Med Econ 25(1):650–659; doi: 10.1080/13696998.2022.2071065 . PMID: 35502563.
View Abstract
Publication: Manuscripts
/ Topics: Health Economics and Outcomes Research (HEOR)
Cardosi L, Rau R, Emdem MR, Kemp R, Minshall M, Pontenani F, Provision S, Sacks N . 2022. Healthcare resource utilization in non-cystic fibrosis bronchiectasis (NCFB) patients with commercial insurance coverage in the US. Value in Health 25(12):S89-S90; doi: 10.1016/j.jval.2022.09.437 .
View Abstract
Publication: Manuscripts
/ Topics: Health Economics and Outcomes Research (HEOR)
Jensen I , Cyr P . 2022. Early health economic models in gene and cell therapy to inform clinical trial design and optimize commercialization efforts. White Paper. PharmaLive .
Publication: White paper
/ Topics: Health Economics and Outcomes Research (HEOR)
Estorninos EM, Cohen S, Reichert H , Lebumfacil J, Jankovic I, Chen Y, Egli D. Real-world effectiveness of young child formula containing Limosilactobacillus reuteri on gastrointestinal tolerance and related behaviors in toddlers: A cross-sectional observational study. Presented at Excellence in Pediatrics (EIP), Amsterdam, Netherlands, December 2022.
Publication: Abstracts and Presentations
/ Topics: Exposure Assessment , food additives , food safety , Food science
Yao W, Jensen I , Claussen M, Dandurand K, Buffington B, Fuentes D, Mikhael M. 2022. Health economics of selective early rescue surfactant administration and standard surfactant administration for newborns with respiratory distress syndrome. J Pediatr Pharmacol Ther 27(8):695–702; doi: 10.5863/1551-6776-27.8.695 . PMID: 36415764.
View Abstract
Publication: Manuscripts
/ Topics: Health Economics and Outcomes Research (HEOR)
Sacks NC . Healthcare resource utilization in non-cystic fibrosis bronchiectasis (NCFB) patients with commercial insurance coverage in the US. Poster presentation, International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Europe, November 2022.
Publication: Abstracts and Presentations
/ Topics: Health Economics and Outcomes Research (HEOR)
Woo K, Fuld R, Grandinetti A, Lawson J, Litchfield T, Ohan M, Peipert JD, Rivara MB, Nordyke RJ . 2022. Patient-reported outcomes in hemodialysis vascular access: A call to action. J Vasc Access 23(6):973-980; doi: 10.1177/11297298211018295 . PMID: 34032166.
View Abstract
Publication: Manuscripts
/ Topics: Epidemiology
Cohen SS, Bylsma LC, Movva N , Alexander DD. 2022. Theoretical attributable risk analysis and Disability Adjusted Life Years (DALYs) based on increased dairy consumption. BMC Public Health 22(1):1625; doi: 10.1186/s12889-022-14042-7 . PMID: 36030208.
View Abstract